Egypt
Research Article
Synthesis and Biological Screening of New Derivatives of 2,3-dihydro
quinazolin-4(1H)-one and Benzotriazepin- 5(2H)-one for Central Nervous
System Activity
Author(s): Samy M Ibrahim, Abo-Kul M, Moustafa K Soltan, Waleed Barakat and Ahmed S HelalSamy M Ibrahim, Abo-Kul M, Moustafa K Soltan, Waleed Barakat and Ahmed S Helal
A new syntheses of novel series of 2,3-dihydroquinazolin-4(1H)-one and benzotriazepin- 5(2H)-one derivatives, starting from the same intermediate (IIa-g). By varying the substituent on the benzamide moiety of the key intermediate (IIa-g) or the conditions of the reactions utilized in this syntheses, the reaction gives rise either quinazolin-4(1H)-one or benzotriazepine-5(2H)-one. The intermediate; 2-methylamino-N-(substituted benzoyl)benzohydrazide (IIa-g); was prepared by condensation of N-methyl-isatoic anhydride with different benzoic acid hydrazides. Constructing the intermediates (IIa-g) on different cyclo-condensation reactions; either with ethylchloroformate /potassium hydroxide or carbon disulfide/potassium hydroxide, yielded a new series of benzotriazepin-5(2H)-one (IIIa-b, IVa-d) and a new series of quinazolin4(1H)-one (Va-c, VI a-d). Pharma.. Read More»
DOI:
10.4172/2161-0444.1000164
Medicinal Chemistry received 6627 citations as per Google Scholar report